Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight

globenewswire.com
CRSP Mentioned in the context of the Genome Editing Market report, which is related to DNA microarray technologies. No specific sentiment expressed towards CRISPR Therapeutics itself. TMO Mentioned in relation to Genome Editing, Genomics, and DNA Sequencing markets. The overall market for DNA microarrays is growing, suggesting a positive environment for companies like Thermo Fisher. EDIT Mentioned in the context of the Genome Editing Market report, which is related to DNA microarray technologies. No specific sentiment expressed towards Editas Medicine itself. LGL Mentioned in the context of the Genome Editing Market report, which is related to DNA microarray technologies. No specific sentiment expressed towards Lonza itself. SANG Mentioned in the context of the Genome Editing Market report, which is related to DNA microarray technologies. No specific sentiment expressed towards Sangamo Therapeutics itself. PRGS Mentioned in the context of the Genome Editing Market report, which is related to DNA microarray technologies. No specific sentiment expressed towards Precision BioSciences itself. CELC Mentioned in the context of the Genome Editing Market report, which is related to DNA microarray technologies. No specific sentiment expressed towards Cellectis S.A. itself. REGN Mentioned in the context of the Genome Editing Market report, which is related to DNA microarray technologies. No specific sentiment expressed towards Regeneron Pharmaceuticals Inc. itself. ILMN Mentioned in relation to Genetic Testing, Genomics, DNA Sequencing, and Next-generation Sequencing markets. The overall market growth for DNA microarrays is positive. MYGN Mentioned in relation to Genetic Testing and Genomics markets. The overall market growth for DNA microarrays is positive. BIIB Mentioned in relation to Genomics, DNA Sequencing, and Next-generation Sequencing markets. The overall market growth for DNA microarrays is positive. DHR Mentioned in relation to Genomics and DNA Sequencing markets. The overall market growth for DNA microarrays is positive. ROST Mentioned in relation to Genomics, DNA Sequencing, and Next-generation Sequencing markets. The overall market growth for DNA microarrays is positive. QGEN Mentioned in relation to Genomics, DNA Sequencing, and Next-generation Sequencing markets. The overall market growth for DNA microarrays is positive. DGX Mentioned in the context of the Genomics Market report. No specific sentiment expressed towards Quest Diagnostics itself. ABT Mentioned in the context of the Genomics Market report. No specific sentiment expressed towards Abbott itself. MRK Mentioned in the context of the DNA Sequencing Market report. No specific sentiment expressed towards Merck & Co., Inc. itself. PACB Mentioned in relation to Genomics, DNA Sequencing, and Next-generation Sequencing markets. The overall market growth for DNA microarrays is positive. AZTA Mentioned as GENEWIZ (Azenta Life Sciences) in the DNA Sequencing and Next-generation Sequencing Market reports. No specific sentiment expressed.

Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight New York, USA, May 06, 2026 (GLOBE NEWSWIRE) -- Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight

The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, genetic disorders, and infectious diseases is driving the adoption of DNA microarray technologies worldwide. Technological advancements in bioinformatics, automation, and high-throughput screening are further supporting market expansion. Additionally, growing investments in biotechnology and pharmaceutical R&D are creating new opportunities for market players.

DelveInsight’s DNA Microarray Market Insights report provides the current and forecast market analysis, individual leading DNA microarray companies’ market shares, challenges, DNA microarray market drivers, barriers, trends, and key DNA microarray companies in the market.

DNA Microarray Market Summary

To read more about the latest highlights related to the DNA microarray market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/dna-microarray-market

Key Factors Contributing to the Rise in Growth of the DNA Microarray Market

Get a sneak peek at the DNA microarray market dynamics @ DNA Microarray Market Trends

Regional DNA Microarray Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the DNA microarray market, get a snapshot of the DNA Microarray Market Share

Recent Developmental Activities in the DNA Microarray Market

What is DNA Microarray?

A DNA microarray is a high-throughput molecular biology tool used to analyze the expression levels of thousands of genes simultaneously or to detect specific DNA sequences within a sample. It consists of a solid surface, such as a glass slide or silicon chip, onto which thousands of microscopic DNA probes are fixed in an organized grid pattern. When fluorescently labeled DNA or RNA samples are applied to the chip, complementary sequences bind to the probes through hybridization, allowing researchers to measure gene activity, identify genetic mutations, study disease mechanisms, and compare gene expression patterns between healthy and diseased tissues. DNA microarrays have become an essential technology in genomics, drug discovery, personalized medicine, and clinical diagnostics due to their ability to generate large-scale genetic data quickly and efficiently.

DNA Microarray Market Assessment

Which MedTech key players in the DNA microarray market are set to emerge as the trendsetter explore @ DNA Microarray Market Analysis

Table of Contents

Interested in knowing the DNA microarray market share by 2034? Click to get a snapshot of the DNA Microarray Market Size

Related Reports

Genome Editing Market

Genome Editing Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key genome editing companies, including CRISPR Therapeutics, Thermo Fisher Scientific Inc., Editas Medicine, Revvity Discovery Limited, Biocompare, CrisprBits, GenAhead Bio Inc., Merck KGaA, GenScript, Agilent Technologies, Inc., Lonza, Tecan Trading AG, Sangamo Therapeutics, Precision BioSciences, Cellectis S.A., Regeneron Pharmaceuticals Inc., AMSBIO, Creative Biogene, Synthego, Takara Bio Inc., and others.

Genetic Testing Market

Genetic Testing Market Insights, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key genetic testing companies, including Illumina, Myriad Genetics, 23andMe, and others.

Genomics Market

Genomics Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key genomics companies, including Thermo Fisher Scientific, Inc., Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., Danaher., F. Hoffmann-La Roche Ltd, Illumina, Inc., Oxford Nanopore Technologies plc., PacBio., QIAGEN, Quest Diagnostics, Myriad Genetics, Inc., Color Health, Inc., Veritas., CD Genomics, GenomSys, IntegraGen, NimaGen B.V., NRGene, Abbott, and others.

DNA Sequencing Market

DNA Sequencing Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key DNA sequencing companies, including Agilent Technologies Inc., Biorad Laboratories Ltd, Danaher Corporation, F. Hoffmann-La Roche Ltd, Illumina Inc, PerkinElmer Inc, Merck & Co., Inc, QIAGEN, Thermo Fisher Scientific, PacBio, Macrogen Inc, Oxford Nanopore Technologies plc, CD Genomics, Takara Bio Inc, Promega Corporation, BGI, 10x Genomics, Eurofins Genomics, GENEWIZ (Azenta Life Sciences), and others.

Next-generation Sequencing Market

Next-generation Sequencing Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key next-generation sequencing companies, including Agilent Technologies, Inc., Illumina Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Thermo Fisher Scientific, PerkinElmer Inc., MedGenome, BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation, NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics, HTG Molecular Diagnostics, Inc., and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.